4
Changes in Ownership
Vericel Corp Filed Acc 0001593968-21-001030
Chief Medical Officer sold 17,924 shares at an average $51.40 ($921,270)
- Chief Medical Officer acquired 33,438 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise | +5,000 | $10.95 | $54,750 | 27,966 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Sale | −5,000 | $50.56 | $252,805 | 22,966 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise | +8,438 | $10.95 | $92,396 | 31,404 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Sale | −1,820 | $51.00 | $92,820 | 29,584 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise | +20,000 | $10.95 | $219,000 | 49,584 | D |
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Sale | −11,104 | $51.84 | $575,645 | 38,480 | D |
| Derivatives | |||||||
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise · Stock Option (right to buy) | −5,000 | 86,736 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise · Stock Option (right to buy) | −20,000 | 66,736 | D | ||
| Hopper Jonathan Mark Chief Medical Officer | 2021-03-30 | Option exercise · Stock Option (right to buy) | −8,438 | 58,298 | D | ||
| Open-market sales · 17,924 sh · avg $51.40 · $921,270 | |||||||
Loading xslF345X03/primary_01.xml…